HEWA Stock Overview
HealthWarehouse.com, Inc. operates an online and mail order pharmacy.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
HealthWarehouse.com, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.12 |
52 Week High | US$0.23 |
52 Week Low | US$0.10 |
Beta | 0.27 |
1 Month Change | 11.23% |
3 Month Change | -11.07% |
1 Year Change | -27.96% |
3 Year Change | -32.34% |
5 Year Change | -59.18% |
Change since IPO | -96.78% |
Recent News & Updates
Recent updates
Shareholder Returns
HEWA | US Consumer Retailing | US Market | |
---|---|---|---|
7D | 2.9% | -1.2% | -3.2% |
1Y | -28.0% | 14.7% | 19.3% |
Return vs Industry: HEWA underperformed the US Consumer Retailing industry which returned 14.7% over the past year.
Return vs Market: HEWA underperformed the US Market which returned 19.3% over the past year.
Price Volatility
HEWA volatility | |
---|---|
HEWA Average Weekly Movement | n/a |
Consumer Retailing Industry Average Movement | 4.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HEWA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HEWA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Joseph Peters | www.healthwarehouse.com |
HealthWarehouse.com, Inc. operates an online and mail order pharmacy. The company markets a range of generic, brand name, and pet prescription medicines, as well as over-the-counter (OTC) medications and products. It sells its products in 50 states and the District of Columbia in the United States to focus on the out-of-pocket prescription drug market.
HealthWarehouse.com, Inc. Fundamentals Summary
HEWA fundamental statistics | |
---|---|
Market cap | US$6.72m |
Earnings (TTM) | -US$2.12m |
Revenue (TTM) | US$20.28m |
0.3x
P/S Ratio-3.2x
P/E RatioIs HEWA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HEWA income statement (TTM) | |
---|---|
Revenue | US$20.28m |
Cost of Revenue | US$8.11m |
Gross Profit | US$12.17m |
Other Expenses | US$14.29m |
Earnings | -US$2.12m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.039 |
Gross Margin | 60.02% |
Net Profit Margin | -10.43% |
Debt/Equity Ratio | 0.0% |
How did HEWA perform over the long term?
See historical performance and comparison